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The human T  cell lymphoma-leukemia virus (HTLV)1 is a novel, type-C retrovirus 
that was isolated from cells of some patients with lymphomas and leukemias of mature 
T  cells  (1,  2).  To show an association of HTLV with particular human malignancies 
and elucidate a possible etiologic role of the virus, we have initiated sero-epidemiologic 
surveys of both patients and normal donors. Three main findings have emerged from 
these studies so far. z First, studies of  Japanese with adult T  cell leukemia (ATL) have 
shown  a  strong  link  with  HTLV.  The  documented  geographic  clustering  of this 
disease in southwestern Japan  initially  indicated  an infectious  vector, possibly viral, 
in  the etiology of the  disease  (3,  4).  Our studies  have shown that  90% of ATL cases 
possess  serum  antibody  to  HTLV  (5,  6).  In  addition,  at  least  10%  of the  normal 
population  in the region where ATL is endemic possess  HTLV-specific antibodies, 2 
which suggests a widespread prevalence of the virus. Japanese investigators have also 
suggested  by serological studies  (7)  that  a  virus was associated  with ATL.  Recently 
Yoshida eta[,  (3)  isolated a  virus from cells of an ATL patient.  We have shown that 
HTLV  is,  in  fact,  the  virus  present  in Japanese  ATL cells  by immunologic studies 
with  purified  HTLV  p24  and  with  a  monoclonal antibody  to  HTLV  p19,  and  by 
nucleic  acid  hybridization  studies  (9).  Second,  we  have  recently  shown  that  the 
Caribbean  basin  is  another  area  where  HTLV-associated  disease  apparently  is  en- 
1  Abbreviations used in this paper: ATL, adult T cell leukemia; CTCL, cutaneous T cell leukemias and 
lymphomas; HTLV, human  T cell leukemia-lymphoma virus; RIA, radioimmunoassay; RIP,  radioim- 
munoprecipitation; T-LCL, T cell lyrnphosarcoma cell leukemia. 
2  Gallo, R. C., et al. The human type-C retrovirus: association wilb a subset ofaduh T cell malig~ancies. 
Manuscript submitted for publication. 
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demic.  Antibodies  to  HTLV  have  been  found  in  eight  out  of eight  cases  of West 
Indian patients  (10) with an aggressive disease similar to ATL, called T  cell lympho- 
sarcoma  cell  leukemia  (T-LCL)  (11),  and  also  in  a  small  percentage  of sera  from 
normal healthy donors from the Caribbean  (10). 2 Third, although HTLV was isolated 
from patients  with  cutaneous  T  cell  leukemias  and  lymphomas  (CTCL),  a  disease 
somewhat  different  from ATL  and  T-LCL,  and  although  natural  antibodies  have 
been  detected  in  sera  from  some  CTCL'patients  (12,  13),  most  CTCL  patients 
surveyed have lacked  HTLV-specific antibodies, z We have postulated  that  a  few of 
the HTLV-associated CTCL patients actually had a disease more akin to ATL, which 
is rarely diagnosed in the United States. 2 At least one of the antibody-positive CTCL 
patients,  however, had a  more typical case of CTCL.  Therefore,  we have not ruled 
out completely an association of HTLV with CTCL. Antibody-negative patients may 
still possess HTLV  information as integrated  proviral sequences.  An HTLV  associa- 
tion of this nature is currently being investigated by molecular hybridization studies. 
In addition, a few of the U.S. patients with an HTLV association have been diagnosed 
as having peripheral  T  cell  lymphoma or malignant  lymphoma of a  diffuse,  mixed 
cell  type.  A  clear HTLV  association  may eventually  aid  in subclassification  of the 
various malignancies of mature T  cells. 
The presence of antibody to HTLV proteins in sera of patients  (or normal donors) 
indicates  prior  infection  by  the  virus.  The  fact  that  the  antibodies  have  shown 
specificity  for internal  structural  proteins  suggests  the  presence  of replicating  virus 
within  the host  cells.  This  evidence,  together with  previous results  that  showed the 
lack of HTLV sequences in DNA of numerous samples from normal uninfected people 
(14) and the presence of HTLV provirus in T  cells but not B cells of the patient from 
whose cells HTLV was isolated  (15), demonstrate that HTLV  is not endogenous but 
rather is acquired by infection.  In this paper we report on serologic studies of family 
members of patients with HTLV-associated disease. The results show that the family 
members are more likely to possess  HTLV-specific antibody than  the normal popu- 
lation, supporting the infectious nature of HTLV. The infectivity of HTLV is further 
illustrated by studies of one family in which four of five members possess either serum 
antibodies specific for HTLV or whose cells express HTLV proteins or release intact 
viral particles. A similar finding of type C viral particles in cultured T  cells of relatives 
of a Japanese ATL patient was recently reported by Miyoshi et al.  (16). 
Materials  and Methods 
Sera.  Samples of human sera or plasma were generally received as frozen or lyophilized 
aliquots. The latter were reconstituted to the original volume before assay. Occasionally, fresh 
samples were obtained for testing. No differences in antibody titers were noted in positive sera 
tested before or after freezing. 
Serologic Assays.  All sera were assayed by at  least  one of the techniques described below. 
Sera of family members were assayed by all three methods. 
A solid-phase radioimmunoassay (RIA) using disrupted HTLV on the solid phase has been 
described (5). In this assay, antibody to any antigen in the HTLV preparation can be detected. 
Antibody specificity for HTLV was determined by competition assays.  Sera were considered 
positive only if their reactivity was competed by extracts of HTLV-producing cells but not by 
extracts of nonproducing cells or fetal calf serum. 
A  competitive  binding  assay  with  a  monoclonal  antibody  to  HTLV  p19  was  used  in 
conjunction with the solid-phase RIA for determining antibody to HTLV p19  (17).  Briefly, 250  HUMAN  T  CELL  LYMPHOMA-LEUKEMIA VIRUS  IN  FAMILY MEMBERS 
serial dilutions of human sera were mixed with a limiting dilution of monoclonal anti-p 19 and 
incubated for 45 min at 37°C on a microtiter plate coated with disrupted HTLV. Those sera 
that  possessed antibody to the same region of p19 as the monoclonal antibody competed for 
binding sites. After washing as in  the solid-phase RIA, binding of the monodonat  anti-pl9 
remaining was detected using iodinated goat anti-mouse IgG. After 45 rain incubation at 37c'C 
and washing, microtiter wells were separated and counted. Competition was calculated based 
on binding of monoclonal antibody in the presence of a pooled normal human serum as 100% 
of maximum (0% competition). 
A  radioimmunoprecipitation  (RIP)  assay  for  purified  HTLV  p24  has  been  described 
previously (6). The specificity of this assay for the major core protein of HTLV and the lack of 
immunologic cross reaction with core proteins of other retroviruses or with cellular proteins has 
been documented (18). 
Cell Culture.  T  cells of an ATL patient and his family members were cultured from viably 
frozen aliquots of peripheral blood lymphocytes. The use of partially purified T  celt growth 
factor in culturing T  lymphocytes has been described (19). 
Detection ofHTL V Antigens.  Expression of HTLV p 19 in cultured T cells was determined by 
indirect immune fluorescent assay on methanol:acetone-fixed cells using a monoclonal antibody 
to HTLV p19 as described (20). Expression of HTLV p24 was determined by competition RIP 
assay of the purified protein.The preparation of the cell lysates and their use as competitors has 
been described (18). The amount of p24 present in cell lysates was determined by comparison 
with a standard curve using purified HTLV p24 as competitor. 
Results and  Discussion 
Relatives of T  Cell Leukemia-Lymphoma Patients Possess HTL V-specific Antibodies.  Sera 
of  family  members  of patients  known  to  be  associated  with  HTLV  by  virtue  of 
possession of HTLV-specific serum  antibodies and/or  expression of HTLV  proteins 
or  production  of intact  viral  particles  by  their  cultured  T  cells  were  assayed  for 
HTLV-specific antibodies as  described  in  Materials  and  Methods.  Table  I  lists  19 
patients known  to be associated with HTLV  and  their family members who  possess 
HTLV-specific  antibodies.  The  families are  grouped  to  demarcate  those  from  the 
United States, the West Indies, and Japan.  Although HTLV-associated disease is not 
known  to  be endemic  in  the  United  States,  the  involvement  of HTLV  in  the  U.S. 
patients  listed  is conclusive.  HTLV  was  first  and  repeatedly  isolated  from  cells of 
patient  C.R.  (1,  15)  and  a  new  isolate has  recently been  obtained  from  cultured  T 
cells of patient M.J. a Both patients were also the subjects of the initial reports on the 
presence  of natural  antibodies  to  HTLV  in  human  sera  (12,  13),  The  presence  of 
antibody to p24 in the wife of patient C.R. was previously reported (13) and continues 
to  be  significant  in  supporting  the  infectivity of HTLV  and  also  in  suggesting  a 
horizontal rather than a  vertical mode of virus transmission. In addition to possessing 
HTLV-specific antibodies, patient W.A. is also the source of one of the new  HTLV 
isolates,  a 
Sera were  available from  family members  of four  patients  from  the  West  Indies 
with aggressive HTLV-associated T  cell malignancies (Table I). Cells of patient M.B. 
were the source of the second isolate of HTLV  (2). The three other patients had T  cell 
lymphosarcoma cell leukemia,  an  aggressive T  cell malignancy similar to Japanese 
ATL (11) and recently shown to be HTLV  associated (10). Although only a  few cases 
have been identified to date, all T-LCL cases from the West Indies studied so far have 
possessed antibodies to HTLV  (10), and of the four families studied here,  three had 
members possessing serum antibodies to HTLV. 
3 Popovic, M., P. S. Sarin, M. Robert-Guroff, V. S. Kalyanaraman, 1). Mann, J. Minowada, and R. C. 
Gallo. Isolation and tra~smission of human  retrovirus (IITI.\:). Manuscripl submilted for publicalion. ROBERT-GUROFF  ET  AL.  251 
TABLE  I 
Presence of Natural Antibodies  to HTL V in Family Members of Patients  with HTL V-associated 
Leukemias  and Lymphornas 
Patient  Diagnosis*  Patient origin 
Antibody in relative 
serum to:~ 
Rela-  Relationship of  Com  tire  positive relative 
sera  to patient  ponents  HTLV  HTLV 
of dis- 
rupted  p24  p19 
HTLV 
Positive/  titer  titer  titer 
Tested 
C.R.  CTCL, M.F.  Alabama  1/4  Wife  200  200  -- 
M.J.  CTCL, Sezary  Massachusetts  0/4  .... 
W.A.  T  cell lym-  Georgia  1/4  Mother  95  3,160  20 
phoma 
M.B.  CTCL, Sezary  West Indies  1/9  Daughter  500  2,500  15 
M.I.  T-LCL  West Indies  1/1  Husband  100  2,070  8 
S.W.  T-LCL  Guyana  0/2  .... 
J.T.  T-LCL  West Indies  1/4  Mother  150  1,520  3 
K.H.  ATL  Japan  1/4  Son  250  1,000  3 
Y.Y.  ATL  Japan  0/2  .... 
K.N.  ATL  Japan  4/8  Wife  175  --  1 
Wife's mother  250  1,000  3 
Son  30  200  -- 
Relative in en-  200  1,500  2 
demic area 
Y.S.  ATL  Japan  1/1  Brother  150  6,400  24 
S.K.  ATL  Japan  2/4  Mother  640  600  20 
Father  35  --  -- 
H.N.  ATL  Japan  4/4  Wife  100  1,710  28 
Daughter  20  35  -- 
Daughter  90  45  -- 
Son  55  20  -- 
H.S.  ATL  Japan  0/1  .... 
H.T.  ATL  Japan  2/3  Brother  35  540  8 
Aunt  30  90  -- 
S.H.  ATL  Japan  3/8  Daughter  40  630  1 
Daughter  65  540  -- 
Daughter  30  --  -- 
K116  ATL  Japan  1/2  Daughter  40  1,710  5 
K119  ATL  Japan  1/1  Wife  60  3,980  14 
T.M.  ATL  Japan  0/2  .... 
* Diagnoses include: CTCL, M.F.  (mycosis fungoides), T-LCL, and ATL. 
:~ Serum  antibodies  were  assayed as  described  in  Materials  and  Methods.  Titers  are  expressed as  the 
reciprocal of the serum dilution giving 50% of maximal binding to components of disrupted HTLV in a 
50-~1 assay; 20% precipitation of HTLV p24 in a  1-ml final volume; and 50% competition of monoclonal 
anti-pl9 in a  50-/tl final volume. 
The  largest  number  of family  member  sera were  obtained  from Japan,  where  ATL 
is  endemic  and  also  HTLV  associated.  Of  the  12  Japanese  families  investigated,  9 
had  antibody-positive  family  members.  The  specificity  of the  antibodies  detected  in 252  HUMAN T  CELL  LYMPHOMA-LEUKEMIA VIRUS  IN  FAMILY  MEMBERS 
positive family member sera has been to HTLV  internal components, which suggests 
not only mere exposure of the individuals to the virus but also actual replication of 
virus within these healthy donors. In only two cases was antibody to both HTLV  p24 
and p19 lacking in a  family member: the father of patient S.K., and the daughter of 
patient  S.H.  (Table I).  The  antigenic component  recognized in  these cases has  not 
been identified, but may be a  viral envelope component. 
HTLV  Antibodies  Are  More  Frequent  in  Healthy  Relatives  than  in  Random  Healthy 
Donors.  Among  healthy  donors  studied,  natural  antibodies  to  HTLV  occur  with 
greater frequency in relatives of patients with HTLV-associated malignancies than in 
randomly  selected normal  donors  ('Fable II).  With regard  to  the  United  States,  an 
endemic area of HTLV-associated  disease has not  been  identified, although  several 
HTLV-associated cases have originated from the southeastern United States. Sporadic 
cases  of U.S.  patients  with  adult  T  cell  malignancies  who  possess  HTLV-specific 
antibodies have  been  clearly demonstrated,  but  so far are rare.  2 Therefore,  the two 
antibody-positive relatives of two  U.S.  patients  (Table I)  are all the  more striking. 
The  percentage  of antibody-positive normal  U.S.  donors  among  relatives  is  much 
greater  than  the  percentage  among  unrelated  healthy  donors  (Table  II),  which 
strengthens  the case  for infection  of individuals having  close contact  with  infected 
patients or a  very similar environment.  Results from the two groups of healthy U.S. 
donors surveyed so far suggest that, as in Japan  (see Fig.  1), tile prevalence of HTLV 
will vary across the country. The apparent difference seen between the Washington, 
DC  area  and  Georgia  may  well  be  explained  by  the  proximity of Georgia to  the 
Caribbean endemic area. 
Similar observations were  made with  both  the Caribbean and Japanese endemic 
populations, where the presence of antibodies to HTLV  among patients is very high. 
Again,  relatives  of  HTLV-associated  patients  from  both  groups  possess  HTLV 
antibodies with  greater  frequency  than  random  normal  donors.  In  the  case of the 
TABLE II 
Prevalence of Natural Antibodies to HTL V in Sera of Patients with Malignancies of Mature T Cells, their 
Healthy Relatives, and Random Normal Donors 
Serum donors 
Antibodies to HTLV* 
Percent  Positive/tested  positive 
Healthy relatives of U.S. patients with HTLV-associ-  2/12 
ated malignancy 
Unrelated healthy donors, Washington, DC  1/185 
Unrelated healthy donors, Georgia  3/158 
Caribbean T-LCL patients 
Healthy relatives of Caribbean patients 
Random healthy donors, Caribbean 
Japanese ATL patients 
Healthy relatives of ATL patients 
Random healthy donors, nonendemic area 
Random  healthy donors, endemic area 
8/8 
3/16 
12/337 
40/46 
19/40 
9/600 
50/419 
17 
<1 
2 
100 
19 
4 
87 
48 
2 
12 
* Antibodies were detected by RIP of HTLV p24 or by the solid-phase RIA. ROBERT-GUROFF  ET AL.  253 
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Flo.  l.  Distribution of HTLV-antibody positive healthy Japanese donors from ATL endemic and 
non-endemic areas. The percentage of positive donors for several areas is indicated. 
Japanese,  random normal donors have been categorized as  from  either the  known 
endemic ATL areas of Kyushu and Shikoku islands (3, 4) or from other areas of  Japan 
not known to be endemic. The distribution of the healthy normal Japanese we have 
surveyed is illustrated in Fig.  1.  Not  all the individuals studied have been mapped 
according to their birthplace. However, certain areas of Kyushu and Shikoku clearly 
have an increased incidence of HTLV exposure. Even taking this geographic distri- 
bution  into  account,  relatives  of  ATL  patients  still  have  a  greater  frequency  of 
antibodies to HTLV  (42%), which again suggests greater exposure to the virus. 
HTI_ V Infection of Relatives of One A TL Patient.  The availability of peripheral blood 
cells from one Japanese ATL patient and his family members has allowed an in-depth 
study of HTLV  infection of this family. A  detailed report on this family, including 
preliminary results on the  HTLV  association, has  been submitted.  4 In addition to 
serological studies showing antibodies to HTLV in the sera of the mother and father 
4  Aoki,  T., A. Shibata, Y. Ohnishi, Y. Aoyagi, H. Miyakoshi,  I. Emura, V. S. Kalyanaraman, M. Robert- 
Guroff, M. G. Sarngadharan, M. Popovic, P. S. Sarin, P. C. Nowell,  and R. C. Gallo. High incidence of the 
human type-C retrovirus HTLV in members of a family of an HTLV-positive Japanese T-cell leukemia 
patient and suggestions  of a preleukemic state in one member. Manuscript submitted for publication. 254  HUMAN T  CELL  LYMPHOMA-LEUKEMIA VIRUS  IN FAMILY MEMBERS 
of the  patient  (S.K.,  Table I),  T  cells of each  family member were  cultured using 
TCGF and subsequently examined for expression of HTLV proteins. HTLV p 19 was 
detected in cells of four of the family members, including the patient (Table III), by 
an indirect immune fluorescent assay using a  monoclonal antibody to  HTLV  p19,  4 
Representative fluorescent staining of p 19-positive T  cells is illustrated in Fig. 2 with 
cells of the mother and father of patient S.K. 
The cultured T  cells of this family were also examined for expression of HTLV p24 
by means of a competition RIP assay for the major core protein using cell extracts as 
competitors.  Again,  the  same  four  individuals, the  ATL  patient  and  his  mother, 
father, and brother, expressed clearly detectable levels of HTLV  p24  (Fig. 3, Table 
III).  It  is  of interest  that  although  three  healthy  family members express  HTLV 
TABLE III 
Expresszon of HTL V Proteins in Cultured Cells of a Japanese  A TL Patient  and His Family Members 
Cell  Cell donor  passage 
Expression of HTLV proteins 
pl9  p24 
Percent positive  ng p24/rng cell 
cells  protein 
ATL patient (S.K.)  2  39  174 
7  61  ND* 
Healthy mother (T.K.)  2  54  800 
Healthy father (H.K,)  3  38  400 
ttealthy brother (B.K.)  2  2  20 
3  13  ND 
Healthy sister (M.K.)  2  0  ND 
3  0  <1 
Expression of HTLV proteins was determined as described in Materials and Methods. 
* Not done. 
Fro.  2.  Fluorescent staining of cultured T cells for HTLV pl9: The indirect immune fluorescent 
assay using a monoclonal antibody to p19 was described in Materials and Methods. Representative 
staining of pl9-positive cells include those from the mother of Japanese ATE patient S.K. (A), and 
those of his father (B). Original magnification × 540. 100  I 
751- 
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Fro.  3.  Competition RIP assay of HTLV p24 by lysates of cultured T  cells of an ATL patient and 
his relatives.  The  ability  of a  limiting dilution  of goat  antiserum to  purified  p24  to  precipitate 
iodinated  HTLV  p24  was competed  by  the  indicated  amounts of cellular  protein.  Competition 
curves are indicated  for HTLV  producer ceils (×)  and  for cultured T  cells of ATL patient  S.K. 
(O), and the patient's mother (Q), father (V1), brother (&), and sister (&). 
proteins, the healthy brother expressed low amounts of both pl9 and p24 and in fact 
also  lacked  detectable  serum  antibody  to  HTLV  antigens.  It will  be of interest  to 
follow this individual with time, as the data suggest he is possibly newly infected. The 
healthy mother of patient S.K. is also of particular interest. Other data have suggested 
that  she  is  in  a  preleukemic  state.  In  particular,  7%  of her  peripheral  blood  cells 
resemble  neoplastic  T  cells  histologically.  4  A  determination  of whether  her  fresh 
uncultured malignant cells also express HTLV proteins is of obvious importance. Her 
cultured  T  cells  do  in  fact  release  HTLV,  as  shown  by  electron  microscopy and 
biochemical studies  (data not shown). 
The pedigrees of all but two of the families illustrate the relationships of the family 
members surveyed and effectively summarize both the serologic and cultured cell data 
(Fig. 4).  In only a  few cases have cells been available for culturing,  even among the 
patients represented, so the lack of data on expression of HTLV in cultured cells does 
not  mean  that  HTLV  proteins  are  not  expressed  in  particular  patients  or  family 
members, or that  HTLV  particles  are not  released.  Cells  have been cultured  from 
U.S. patients C.R. and M.J., West Indian patients M.I. and M.B., and the Japanese 
ATL patient S.K. In each case, after culture with TCGF we have been aMe to obtain 
cells either expressing HTLV proteins or releasing intact viral particles (1, 2).  2,4 One 
might  expect,  therefore,  that  if cells  were  cultured  from  other  antibody-positive 
patients, HTLV expression would also be detected. 
With  regard  to  the  serum  antibody-positive healthy  relatives,  we  have  had  the 
opportunity to culture cells of six individuals:  the wife of C.R., the daughter of M.B., 
and the  four family members of patient  S.K.  The cultured  T  cells of the  first  two 
individuals have been negative for expression of HTLV proteins, whereas three of the 
latter were positive for HTLV antigen expression. As we mentioned above, the healthy 
brother of S.K. lacked serum antibody to HTLV, but expression of HTLV proteins 
was  observed  in  his  cultured  T  cells.  The  factors controlling  expression  or  lack of 
expression  of  HTLV  in  these  healthy  individuals  exposed  to  HTLV  are  under 
investigation. Items of major importance include length of time post-HTLV infection, 256  HUMAN T  CELL  LYMPHOMA-LEUKEMIA VIRUS  IN FAMILY MEMBERS 
PEDIGREES  OF PATIENT  FAMILIES INFECTED  WITH  HTLV 
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Fro.  4.  Pedigrees  of families infected with  HTLV.  Both  the  presence  o£ natural  antibodies to 
HTLV and the expression of HTLV proteins in cultured cells of patients and family members are 
summarized graphically. Cells for culture were available in only a few caes (see text). The lack of 
information on HTLV antigen expression or particle release therefore does not necessarily  indicate 
the absence of HTLV information in particular family members. 
age at time of infection, and immunological competence of infected individuals. This 
healthy brother of S.K. further serves to emphasize the point that antibody-negative 
cases are not necessarily uninfected by HTLV. 
With regard to only the serologic studies, the data summarized in Fig. 4 would not 
rule out any particular mode of HTLV transmission. Although strict vertical genetic 
transmission in the  sense of endogenous retroviruses has  been ruled out  by nucleic 
acid hybridization studies (14,  15), one cannot rule out other possibilities, including 
congenital infections, milk-borne transmissions, and other types of horizontal trans- 
mission. 
Of the  19 families studied here,  14 had at  least  1 healthy member who possessed 
HTLV antibodies. Of the five families with no antibody-positive healthy members, 
four  were  represented  by  a  very  small  number of donors  who  were  perhaps  not 
representative of the entire family. The  fact  that  the overall prevalence of HTLV ROBERT-GUROFF  ET AL.  257 
infection of family members, reflected by their possession of HTLV antibodies, is 
greater  than  that  of randomly  selected  normal  donors  (Table  II)  supports  the 
infectious nature of HTLV and further suggests its involvement with the particular 
diseases represented here. 
Summary 
Sera of family members of patients from the United States,  the Caribbean, and 
Japan,  with  human  T  cell  lymphoma-leukemia virus  (HTLV)  associated  T  cell 
malignancies, possess HTLV-specific antibodies directed against internal structural 
components of HTLV, p24 and p 19. The prevalence of  antibodies to HTLV is greater 
in  family members than in random healthy donors,  which supports the infectious 
nature of HTLV and its association with particular aggressive T  cell malignancies. 
Expression of HTLV p24 and p19 has also been observed  in cultured T cells of some 
healthy relatives,  and  intact  virus  particles  have  been  released  from cells  of one 
possibly pre-leukemic family member. 
Received  for publication 16 August  1982. 
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